Performing fungal diagnostic preparations to confirm a suspected fungal infection should be a central tenant in dermatology, says this expert. But more than one-fifth of dermatologists surveyed said they never or rarely do fungal preparations in practice.
A recent study examines the safety and efficacy of picosecond laser as a melasma treatment during a time when lasers are increasingly being used to treat the condition.
The United States Food and Drug Administration has granted Galderma’s nemolizumab a Breakthrough Therapy Designation following phase 2 results which suggests the drug is a considerable alleviant for pruritus associated with prurigo nodularis.
Leo Pharma A/S and Portal Instruments are now collaborating on a new needle-free handheld jet injector for patients that self-administer medicines for cutaneous diseases and ailments.
In the decades that Dermatology Times reporters have covered the specialty, we’ve had the pleasure of profiling the specialty’s champions. Some shared their professional accomplishments, while others revealed unknown aspects of their personal lives. Here just some of the interesting tidbits from years’ past.
Study shows clinical benefit of PRP in a stabilized vehicle for SoME Skincare product.
Allan C. Halpern, M.D., discusses what dermatologists need to understand about AI and how it might interact with or disrupt the specialty.
As non-surgical aesthetic procedures continue to grow, so do the number of medical spas that perform cosmetic treatments. According to Dr. Renato Saltz, that’s not necessarily a bad thing.
According to Dr. Gary Linkov, effectively evaluating hair loss in women requires a strategic approach and comprehensive patient consultation.
CBD is taking the market by storm, but does it offer benefits to the skin itself? With their new line of CBD skincare and wellness products, Dermaquest says yes.
Oculoplastic surgeon William Mack, M.D., says identifying and surgically correcting (or referring) ptosis in cosmetic blepharoplasty patients is key to delivering optimal results.
According to Dr. Michael Somenek, the key to great results and happy male patients is knowing how to treat his face without feminizing his features.
To recognize Antibiotic Awareness Week, we’ve gathered articles on antibiotic use in acne, alternative therapies and treatment trends in the specialty. View the highlights in this slideshow.
Instagram and Snapchat may be detrimental to young people’s mental health. But can (and should) Instagram shield youth from cosmetic surgery procedure posts?
Dr. Wever discusses the prevalence of BDD in the aesthetic practice and how to identify the psychological disorder.
By the end of a three-day weekend, five of the teams at Hacking Dermatology's 2019 Hackathon walked away with $5,000 each. Learn more about the collaboration that took place and the solutions each team developed to solve pressing problem areas in dermatology.
Brett Coldiron, M.D., offers insight on how recent legislative and regulatory changes may impact your practice.
Stay up-to-date on the most recent clinical advances in atopic dermatitis.
The appointment of Mary Lynn Moran, M.D., F.A.C.S., as the first female president of AAFPRS suggests growth in female access to leadership roles in the medical aesthetics industry.
In this month's Innovation article, Steve Xu, M.D., FAAD, highlights a company and innovator who are using artificial intelligence to augment physician decision-making, not replace it.
Dr. Chilukuri discusses how to create a smooth and prosperous transition for that new device into your practice.
Two physicians talk over-filled lips – why they happen and tips for more natural treatment results.
Connell announces exclusive distribution agreement for Asia-Pacific with biodesign company, Geltor, known for its 100% animal- and GMO-free proteins.
Drug development in acne is currently focused on targeting inflammation and reworking the vehicles of existing active drugs to increase their efficacy and tolerability, according to this expert.
Interleukin-29 (IL-29) is a newly discovered cytokine that has become the subject of increased research attention for its role in inflammation and inflammatory autoimmune disorders and therefore as a target for novel therapeutic development.
Clascoterone 1% cream is in late stage development for acne treatment and in a higher strength solution for androgenetic alopecia. Read more about this novel treatment here.
Drs. Lilit Garibyan, Steve Xu and Kachiu C. Lee highlight a grassroots initiative that encourages physicians to become more involved in innovation in dermatology.
To recognize the one year anniversary of our Innovation column, the Dermatology Times Staff has compiled key takeaways from topics covered throughout the year. View them in this slideshow.
Another neurotoxin is in the pipeline, but will this one fill an unmet need? Dr. Joel Cohen explains.